Penumbra Inc Stock
Pros and Cons of Penumbra Inc in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Penumbra Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Penumbra Inc | 0.220% | -0.643% | 0.072% | 33.654% | 4.354% | 2.963% | 23.446% |
| Haemonetics Corp. | 1.340% | 5.797% | 10.606% | - | 6.569% | - | - |
| Bio-Rad Labs Inc. A | 3.260% | 2.732% | 9.502% | 16.037% | 10.818% | -23.048% | -54.272% |
| CONMED Corp. | -0.990% | 7.447% | 41.259% | -8.597% | 15.429% | -62.936% | -64.870% |
News
3 Medical Device Stocks Giving Investors a Different Healthcare Play
Key Points
- Interested in Globus Medical, Inc.? Here are five stocks we like better.
- Globus Medical continues to grow revenue and earnings as its spine, musculoskeletal and enabling technology
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity
Medical device manufacturer Boston Scientific Corp. (NYSE: BSX) is seemingly off to a tough start to the year, as shares have plunged by 26% year-to-date (YTD) and by almost a third in the last